Cell Analysis Global Market estimated to be worth $39.3 billion by 2025

IQ4I Research & Consultancy published a new report on “Cell Analysis Global Market-Forecast to 2025”.

Techniques:
• Molecular approach
 PCR
 Sequencing
 Microfluidics and Microarrays
 Cell separation and isolation techniques
• Image-Based Approach
 Microscopy
 Cytometry
 High Content Screening
 Spectrophotometry

Products:
• Consumables
• Assay Kits
• Microplates
• Reagents
• Cell culture consumables
• Others
• Instruments
• Cell Counters
• Cell Microarrays and Microfluidics
• Liquid handling systems
• Cytometers
• High Content Screening
• Microplate readers
• PCR Instruments
• Sequencing instruments
• Spectrophotometers
• Microscopes
• Others Instruments
• Software and Services

Application:
• Process of application
• Cellular processes
• Circulating Tumor Cells
• Signal Transduction Pathway
• Subpopulation Characterization
• Drug and Candidate Screening
• Single-cell analysis
• Epigenetic target analysis
• Field of Application
 Forensic
 Therapeutics
 Cell Imaging
 Biomarker research
 Genomic analysis
 Stem cell analysis
 Diagnostics
• Therapeutic Area of Application
 Cancer research
 Infectious disease diagnosis
 Genetic testing
 Immunology
 Others

End Users:
• Hospitals
• Academics and Research Institutes
• Contract Research Organizations
• Pharmaceuticals & Biotech companies
• Cell Banks
• Diagnostic Laboratories
• Others (Blood banks, ambulatory surgical centers)

Geography:
• North America
• Europe
• Asia-Pacific
• Rest of the World

According to IQ4I analysis, the cell analysis global market is estimated to grow at high single digit CAGR to reach $39.3 billion by 2025. Some of the factors driving the market are raising incidence of life-threatening infectious diseases, increasing funding and investments in cell-based research from government and corporate, high demand for cell analysis products by end-users, emerging Asia-Pacific market, emerging cell analysis service providers and introduction of automation technologies in cancer research. However, stringent government regulations, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth.
The report covers information such as, analysis of segments by techniques, products, applications end-users and geography, market share analysis by major players and single-cell analysis, and cost of major devices. Also includes, Profiles of major players and analysis of their revenue, business strategies, SWOTs and market share.
Major players in cell analysis market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.S.), Merck KGaA (Germany), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), Qiagen N.V. (Netherlands), GE Healthcare (U.S.) and ThermoFisher Scientific, Inc. (U.S.).

For more details please visit our website or contact:
Mr. Satish Birudukota,
Website: https://www.iq4i.com
Report link: https://www.iq4i.com/reports-category/biotechnology/r/74
Email: bd@iq4i.com, satish.birudukota@iq4i.com,
Phone: +91-9886722024, 8147030229,

IQ4I Research & Consultancy Pvt. Ltd.
No 41/P4, Industrial Suburb
1st Floor, 3rd Main Road
1st Phase, KIADB Industrial Area
Peenya, Bangalore-560058

IQ4I (Intelligence Quotient for Innovation) Research and Consultancy Pvt. Ltd. is a global strategy, consulting and a leading market research company. Our clients include leading businesses, investment banks, researchers and government agencies.

We are a team of highly qualified consultants and market researchers, committed to help clients make strategic decisions by providing relevant and firmly reliable market intelligence support. We enable our clients to identify the market opportunities with best-in-class market intelligence reports.

This release was published on openPR.